Gut Microbiome Alterations in Patients With Thyroid Nodules

被引:28
|
作者
Li, Ang [1 ]
Li, Tiantian [1 ]
Gao, Xinxin [1 ]
Yan, Hang [1 ]
Chen, Jingfeng [1 ]
Huang, Meng [1 ]
Wang, Lin [1 ]
Yin, Detao [2 ]
Li, Hongqiang [2 ]
Ma, Runsheng [2 ]
Zeng, Qiang [3 ,4 ]
Ding, Suying [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Hlth Management Ctr, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Dept Thyroidol, Zhengzhou, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 2, Hlth Management Inst, Beijing, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China
关键词
thyroid nodule; thyroid function; gut microbiota; metagenomics; comparative genomics; gut-thyroid link;
D O I
10.3389/fcimb.2021.643968
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Thyroid nodules are found in nearly half of the adult population. Accumulating evidence suggests that the gut microbiota plays an important role in thyroid metabolism, yet the association between gut microbiota capacity, thyroid nodules, and thyroid function has not been studied comprehensively. We performed a gut microbiome genome-wide association study in 196 patients with thyroid nodules and 283 controls by using whole-genome shotgun sequencing. We found that participants with high-grade thyroid nodules have decreased number of gut microbial species and gene families compared with those with lower grade nodules and controls. There are also significant alterations in the overall microbial composition in participants with high-grade thyroid nodules. The gut microbiome in participants with high-grade thyroid nodules is characterized by greater amino acid degradation and lower butyrate production. The relative abundances of multiple butyrate producing microbes are reduced in patients with high-grade thyroid nodules and the relative abundances of L-histidine metabolism pathways are associated with thyrotropin-releasing hormone. Our study describes the gut microbiome characteristics in thyroid nodules and a gut-thyroid link and highlight specific gut microbiota as a potential therapeutic target to regulate thyroid metabolism.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Gut Microbiome Alterations in COVID-19
    Zuo, Tao
    Wu, Xiaojian
    Wen, Weiping
    Lan, Ping
    GENOMICS PROTEOMICS & BIOINFORMATICS, 2021, 19 (05) : 679 - 688
  • [42] Alterations of the human gut microbiome in liver cirrhosis
    Nan Qin
    Fengling Yang
    Ang Li
    Edi Prifti
    Yanfei Chen
    Li Shao
    Jing Guo
    Emmanuelle Le Chatelier
    Jian Yao
    Lingjiao Wu
    Jiawei Zhou
    Shujun Ni
    Lin Liu
    Nicolas Pons
    Jean Michel Batto
    Sean P. Kennedy
    Pierre Leonard
    Chunhui Yuan
    Wenchao Ding
    Yuanting Chen
    Xinjun Hu
    Beiwen Zheng
    Guirong Qian
    Wei Xu
    S. Dusko Ehrlich
    Shusen Zheng
    Lanjuan Li
    Nature, 2014, 513 : 59 - 64
  • [43] Alterations of mouse gut microbiome in alveolar echinococcosis
    Cui, Ziyan
    Du, Fei
    Yu, Wenhao
    Wang, Zhixin
    Kong, Fanyu
    Xie, Zhi
    Zhao, Qian
    Zhang, Hanxi
    Wang, Haijiu
    Fan, Haining
    Ren, Li
    HELIYON, 2024, 10 (12)
  • [44] Glioma and temozolomide induced alterations in gut microbiome
    Patrizz, Anthony
    Dono, Antonio
    Zorofchian, Soheil
    Hines, Gabriella
    Takayasu, Takeshi
    Husein, Nuruddin
    Otani, Yoshihiro
    Arevalo, Octavio
    Choi, H. Alex
    Savarraj, Jude
    Tandon, Nitin
    Ganesh, Bhanu P.
    Kaur, Balveen
    McCullough, Louise D.
    Ballester, Leomar Y.
    Esquenazi, Yoshua
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [45] Glioma and temozolomide induced alterations in gut microbiome
    Anthony Patrizz
    Antonio Dono
    Soheil Zorofchian
    Gabriella Hines
    Takeshi Takayasu
    Nuruddin Husein
    Yoshihiro Otani
    Octavio Arevalo
    H. Alex Choi
    Jude Savarraj
    Nitin Tandon
    Bhanu P. Ganesh
    Balveen Kaur
    Louise D. McCullough
    Leomar Y. Ballester
    Yoshua Esquenazi
    Scientific Reports, 10
  • [46] Gut microbiome alterations in Alzheimer’s disease
    Nicholas M. Vogt
    Robert L. Kerby
    Kimberly A. Dill-McFarland
    Sandra J. Harding
    Andrew P. Merluzzi
    Sterling C. Johnson
    Cynthia M. Carlsson
    Sanjay Asthana
    Henrik Zetterberg
    Kaj Blennow
    Barbara B. Bendlin
    Federico E. Rey
    Scientific Reports, 7
  • [47] Alterations of the human gut microbiome in multiple sclerosis
    Jangi, Sushrut
    Gandhi, Roopali
    Cox, Laura M.
    Li, Ning
    von Glehn, Felipe
    Yan, Raymond
    Patel, Bonny
    Mazzola, Maria Antonietta
    Liu, Shirong
    Glanz, Bonnie L.
    Cook, Sandra
    Tankou, Stephanie
    Stuart, Fiona
    Melo, Kirsy
    Nejad, Parham
    Smith, Kathleen
    Topcuolu, Begum D.
    Holden, James
    Kivisakk, Pia
    Chitnis, Tanuja
    De Jager, Philip L.
    Quintana, Francisco J.
    Gerber, Georg K.
    Bry, Lynn
    Weiner, Howard L.
    NATURE COMMUNICATIONS, 2016, 7
  • [48] Alterations of the human gut microbiome in multiple sclerosis
    Jangi, S.
    Gandhi, R.
    Li, N.
    Von Glehn, F.
    Yan, R.
    Melo, K.
    Mazzola, M.
    Patel, B.
    Glanz, B.
    Cook, S.
    Stuart, F.
    Holden, J.
    Kivisakk, P.
    De Jager, P.
    Chitnis, T.
    Bakshi, R.
    Quintana, F.
    Gerber, G.
    Bry, L.
    Weiner, H.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 168 - 168
  • [49] Gut Microbiome Alterations in COVID-19
    Tao Zuo
    Xiaojian Wu
    Weiping Wen
    Ping Lan
    Genomics,Proteomics & Bioinformatics, 2021, (05) : 679 - 688
  • [50] Alterations of gut microbiome in eosinophilic chronic rhinosinusitis
    Liang, Yibo
    Zhang, Chenting
    Xiong, Xin
    Mao, Xiang
    Sun, Peiyong
    Yue, Zhenzhong
    Wang, Wei
    Xie, Runxiang
    Zhang, Guimin
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, 281 (12) : 6459 - 6468